Neuromyelitis optica in patients with coexisting human immunodeficiency virus infections

Multiple Sclerosis Journal

Volumn 19, Issue 10, 2013, Pages 1363-1366

  Feyissa, Anteneh M ^a   Singh, Parbhdeep ^a   Smith, Robert G ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Aquaporin 4 antibody; Devic's disease; HIV; neuromyelitis optica; NMO; plasma exchange

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; AQUAPORIN 4 ANTIBODY; GLUCOSE; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; PROTEIN; RITUXIMAB;

ADULT; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID LEVEL; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE COURSE; DRUG MEGADOSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGLOBULIN BLOOD LEVEL; MAINTENANCE THERAPY; MALE; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; PROTEIN CEREBROSPINAL FLUID LEVEL; RELAPSE; VISUAL IMPAIRMENT; WEAKNESS;

AQUAPORIN-4 ANTIBODY; DEVIC'S DISEASE; HIV; NEUROMYELITIS OPTICA; NMO; PLASMA EXCHANGE;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEUROMYELITIS OPTICA;

EID: 84883362957     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458513483891     Document Type: Article

References (13)

1. Jarius S, Ruprecht K, Wildemann B, et al. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflammation. 2012 ; 9: 14
2. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006 ; 66: 1485-1489
3. Maureen MA, Wingerchuk DM, Greenberg BM, et al. Epidemiology of neuromyelitis optica in the United States. Arch Neurol. 2012 ; 69: 1176-1180
4. Wilcox RA, Burrow J, Slee M, et al. Neuromyelitis optica (Devic's disease) in a patient with syphilis. Mult Scler. 2008 ; 14: 268-271
5. Blanche P, Diaz E, Gombert B, et al. Devic's neuromyelitis optica and HIV-1 infection. J Neurol Neurosurg Psychiatry. 2000 ; 68: 795-796
6. Merle H, Smadja D, Cordoba A.. Neuromyélite optique et nécrose rétinienne aigüe bilateral d'origine zostérienne chez une patiente atteinte du SIDA. J Fr Ophtalmol. 1998 ; 21: 381-386
7. Berger JR, Tornatore C, Major EO, et al. Relapsing and remitting human immunodeficiency virus-associated leukoencephalopathy. Ann Neurol. 1992 ; 31: 34-38
8. Coban A, Akman-Demir G, Ozsut H, et al. Multiple sclerosis-like clinical and magnetic resonance imaging findings in human immunodeficiency virus positive-case. Neurologist. 2007 ; 13: 154-157
9. Saito Y, Sharer LR, Epstein LG, et al. Overexpression of Nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology. 1994 ; 44: 474-487
10. Collongues N, de Seze J. Current and future treatment approaches for neuromyelitis optica. Ther Adv Neurol Disord. 2011 ; 4: 111-121
11. Ciuffreda D, Pantaleo G, Pascual M. Effects of immunosuppressive drugs on HIV infection: Implications for solid-organ transplantation. Transpl Int. 2007 ; 20: 649-658
12. Clifford DB, Ances B, Costello C, et al. Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis. Arch Neurol. 2011 ; 68: 1156-1164
13. Pellkofer HL, Krumbholz M, Berthele A, et al. Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab. Neurology. 2011 ; 76: 1310-1315